GlassScriptPhysician profile
Angelo W Kanellos
NPI 1013008135
$11,289.25
in general payments reported to CMS, 2019-2025
33 companies · $462 in 2025
The $462 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $218 · 2021: $4,011 · 2022: $870 · 2023: $3,222 · 2024: $2,370 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,473 · Food and Beverage: $2,392 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,472.87 |
| Food and Beverage | $2,392.08 |
| Education | $189.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $4,058.63 | 2023-2024 | Nanoknife |
| Exelixis INC. | $1,470.00 | 2021 | |
| Janssen Biotech, INC. | $1,379.53 | 2019-2025 | Erleada, Akeega |
| Cipla USA INC. | $1,095.34 | 2021 | |
| Edap Technomed INC | $540.56 | 2023 | |
| Astellas Pharma US INC | $481.26 | 2021-2024 | Xtandi |
| Abbvie INC. | $388.18 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $281.51 | 2023-2025 | Orgovyx |
| Merck Sharp & Dohme LLC | $204.05 | 2021-2024 | Keytruda |
| Myriad Genetic Laboratories, INC. | $174.83 | 2022-2023 | Myrisk, Prolaris, Precisetumor |
| Progenics Pharmaceuticals, INC. | $145.16 | 2023-2025 | Pylarify |
| Intuitive Surgical, INC. | $123.03 | 2023 | |
| Myovant Sciences INC. | $101.37 | 2022 | |
| Verity Pharmaceuticals INC. | $83.80 | 2021-2022 | |
| Boston Scientific Corporation | $76.98 | 2020-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $73.13 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.40 | 2022-2023 | |
| Accord Healthcare, INC. | $69.14 | 2023-2024 | |
| Dendreon Pharmaceuticals LLC | $60.60 | 2020-2022 | |
| Amgen INC. | $50.74 | 2021-2023 | Xgeva |
| Janssen Scientific Affairs, LLC | $42.71 | 2025 | Axert |
| Astrazeneca Pharmaceuticals LP | $42.55 | 2023-2024 | Lynparza |
| Koelis INC. | $36.71 | 2023 | |
| Agiliti Surgical, INC. | $36.71 | 2023 | Sonablate, Trinity |
| 180 Medical, INC. | $33.29 | 2019-2021 | |
| Urogen Pharma, INC. | $32.37 | 2022 | |
| Allergan, INC. | $29.62 | 2022 | |
| Pfizer INC. | $23.93 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $21.83 | 2022 | |
| Endo Pharmaceuticals INC. | $18.32 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.81 | 2022 | |
| Blue Earth Diagnostics | $14.51 | 2021 | |
| Profound Medical Corp. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Kanellos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.